Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Rehabilitation in Gastric Cancer
NCT06419140Phase 2Not yet recruiting
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Jun 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Adjuvant chemotherapy completion rate. Planned start Jun 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06419140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419140.